What's new
Information from the previous month appears monthly in the newsletter “What'sNew” (link to registration page).
For the RSS feed with daily notifications of updates, use the link: RSS feed for “What'sNew”.
Search narrowed by
Atenolol New
PSUR-outcome
|
28/11/2025
Further information and amendments to the product information in all EU languages are available on the EMA website.
Dorzolamide/Timolol New
Additional template
|
27/11/2025
Further information can be found in the CMDh minutes from october 2025.
Dorzolamide New
PSUR-outcome
|
27/11/2025
Further information and amendments to the product information in all EU languages are available on the EMA website.
Gabapentin New
PSUR-outcome
|
27/11/2025
Further information and amendments to the product information in all EU languages are available on the EMA website.
Prednisone New
PSUR-outcome
|
26/11/2025
Further information and amendments to the product information in all EU languages are available on the EMA website.
Trimethoprim New
PSUR-outcome
|
26/11/2025
Further information and amendments to the product information in all EU languages are available on the EMA website.
Sodium citrate / sodium lauryl sulfoacetate, sodium citrate / sodium lauryl sulfoacetate / sorbitol New
PSUR-outcome
|
26/11/2025
Further information and amendments to the product information in all EU languages are available on the EMA website.
Caspofungin New
PSUR-outcome
|
25/11/2025
Further information can be found in the Commission Decision and its annexes, which are available in all EU languages on the European Commission's (EC) website.
Bosutinib New
PRAC signal recommendation
|
24/11/2025
Risk for cutaneous vasculitis. Further information and amendments to the product information can be found on the EMA website.
Botulinum toxin a (except for centrally authorised products) New
PSUR-outcome
|
06/11/2025
Further information and amendments to the product information in all EU languages are available on the EMA website.